A Meta-Analysis Assessing Additional LDL-C Reduction from Addition of a Bile Acid Sequestrant to Statin Therapy - 05/11/20
, Aakash Bavishi, MD, Katelyn Zumpf, MS, Jonna Peterson, MLIS, Neil J. Stone, MDAbstract |
Background |
Statins are the first-line therapy for reducing low-density lipoprotein cholesterol (LDL-C). However, there are secondary prevention patients who are either intolerant to maximal statin therapy or do not get adequate effects from a high-intensity statin. While data exist for the additional LDL-C-lowering effects of ezetimibe, there are no data on additional LDL-C lowering of bile acid sequestrants when combined with statin therapy. The purpose of this study was to quantify the LDL-C-lowering effects of bile acid sequestrants when added to statin therapy.
Methods |
Databases (Medline via PubMed, Embase, and the Cochrane Library) were searched for randomized controlled trials comparing statin therapy to statin therapy with the addition of bile acid sequestrants. Nine studies were included in the meta-analysis. A meta-regression was performed to estimate the mean difference in LDL-C between the 2 groups.
Results |
Without controlling for other variables, data suggest that combining statin with bile acid sequestrant increases the percentage change in LDL-C by 16.2 points, on average, compared with statin use alone.
Conclusion |
In patients unable to tolerate an adequate statin dosage, bile acid sequestrants offer a viable alternative with additional LDL-C-lowering benefit.
El texto completo de este artículo está disponible en PDF.Keywords : Bile acid sequestrants, Cholesterol, LDL-C, Lipid, Preventative cardiology, Statins
Esquema
| Funding: None. |
|
| Conflict of Interest: The authors certify that they all have NO affiliations with, or involvement in, any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. |
|
| Authorship: All of the authors had access to the data and a role in writing the manuscript. MA: data collection and primary author; AB: data collection; KZ: statistical analysis; JP: library science; NJS: senior author. |
Vol 133 - N° 11
P. 1322-1327 - novembre 2020 Regresar al número
Artículo precedente
- Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team
- Brett J. Carroll, Sebastian E. Beyer, Tyler Mehegan, Andrew Dicks, Abby Pribish, Andrew Locke, Anuradha Godishala, Kevin Soriano, Jaya Kanduri, Kelsey Sack, Inbar Raber, Cara Wiest, Isabel Balachandran, Mason Marcus, Louis Chu, Margaret M. Hayes, Jeff L. Weinstein, Kenneth A. Bauer, Eric A. Secemsky, Duane S. Pinto
- Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest
- Ying X. Gue, Max Sayers, Benjamin T. Whitby, Rahim Kanji, Krishma Adatia, Robert Smith, William R. Davies, Aris Perperoglou, Tatjana S. Potpara, Gregory Y.H. Lip, Diana A. Gorog
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?